Sonavex, Inc.: Clinical Trials

5 trials sponsored by Sonavex, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 terminated, 1 completed. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Completed 1

Follow Sonavex, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of 3D Ultrasound for Support of Hemodialysis Cannulation
EchoMap, Standard of Care Cannulation - Dialysis
Not applicableRecruitingSonavex, Inc.202026-05-072026-10-27
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
EchoMark/EchoSure, Standard of Care - Diabetes, End Stage Renal Disease
Not applicableRecruitingSonavex, Inc.3042024-02-212026-10-16
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
EchoMark / EchoSure - Kidney Diseases, Arteriovenous Fistula
Not applicableCompletedSonavex, Inc.202022-01-212026-05-20
Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients
EchoMark/EchoSure - Arteriovenous Fistula, Arteriovenous Graft
TerminatedSonavex, Inc.172019-12-022022-10-12
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
EchoMark, EchoSure - Free Flap Transfer, Malignant Neoplasm
TerminatedSonavex, Inc.142019-09-192024-11-26

Conditions studied

Arteriovenous Fistula (2)  ·  Diabetes Mellitus (1)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Neoplasms (1)

Interventions

Standard of Care (1)

Countries

United States (5)

NIH funding

R44HL147423 (2), R44DK131644 (1)